The DOI matches its Crossref record; 436 of the 436 references it cites were found in a registry or an index.
The amyloid cascade hypothesis: an updated critical review
Open accessAbstract
Results from recent clinical trials of antibodies that target amyloid-β (Aβ) for Alzheimer’s disease have created excitement and have been heralded as corroboration of the amyloid cascade hypothesis. However, while Aβ may contribute to disease, genetic, clinical, imaging and biochemical data suggest a more complex aetiology. Here we review the history and weaknesses of the amyloid cascade hypothesis in view of the new evidence obtained from clinical trials of anti-amyloid antibodies. These trials indicate that the treatments have either no or uncertain clinical effect on cognition. Despite the importance of amyloid in the definition of Alzheimer’s disease, we argue that the data point to Aβ playing a minor aetiological role. We also discuss data suggesting that the concerted activity of many pathogenic factors contribute to Alzheimer’s disease and propose that evolving multi-factor disease models will better underpin the search for more effective strategies to treat the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 436
Physiological roles for amyloid β peptides
Pearson, H. A., & Peers, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111203 · Cited by 286
Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., Pollwein, P., Beyreuther, K., & Masters, C. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85394-2 · Cited by 286
A resurrection of aducanumab for Alzheimer's disease
Schneider, L. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30480-6 · Cited by 286
Faller, P. (2009) · ChemBioChem · doi:10.1002/cbic.200900321 · Cited by 285
Copper and Zinc Dysregulation in Alzheimer’s Disease
Sensi, S. L., Granzotto, A., Siotto, M., & Squitti, R. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.10.001 · Cited by 285
Self-citationTau phosphorylation and aggregation in Alzheimer's disease pathology
Avila, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.067 · Cited by 282
Schmitz, C., Rutten, B. P. F., Pielen, A., Schäfer, S., Wirths, O., Tremp, G., Czech, C., Blanchard, V., Multhaup, G., Rezaie, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63235-x · Cited by 281
Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
Pimplikar, S. W., Nixon, R. A., Robakis, N. K., Shen, J., & Tsai, L.-H. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4305-10.2010 · Cited by 281
Self-citationArnáiz, E., & Almkvist, O. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.107.s179.7.x · Cited by 281
Potent amyloidogenicity and pathogenicity of Aβ43
Saito, T., Suemoto, T., Brouwers, N., Sleegers, K., Funamoto, S., Mihira, N., Matsuba, Y., Yamada, K., Nilsson, P., Takano, J., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2858 · Cited by 280
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease
Farlow, M., Arnold, S. E., van Dyck, C. H., Aisen, P. S., Snider, B. J., Porsteinsson, A. P., Friedrich, S., Dean, R. A., Gonzales, C., Sethuraman, G., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.09.224 · Cited by 280
Lessons from a failed γ-secretase Alzheimer trial
De Strooper, B. (2014) · Cell · doi:10.1016/j.cell.2014.10.016 · Cited by 277
Neuroinflammation in Alzheimer’s disease
Zhang, F., & Jiang, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75546 · Cited by 276
Karran, E., & Hardy, J. (2014) · Annals of Neurology · doi:10.1002/ana.24188 · Cited by 275
A study on the association between infectious burden and Alzheimer's disease
Bu, X. ‐., Yao, X. ‐., Jiao, S. ‐., Zeng, F., Liu, Y. ‐., Xiang, Y., Liang, C. ‐., Wang, Q. ‐., Wang, X., Cao, H. ‐., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12477 · Cited by 273
Aβ42 is More Rigid than Aβ40 at the C Terminus: Implications for Aβ Aggregation and Toxicity
Yan, Y., & Wang, C. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.046 · Cited by 273
Tucker, S., Möller, C., Tegerstedt, K., Lord, A., Laudon, H., Sjödahl, J., Söderberg, L., Spens, E., Sahlin, C., Waara, E. R., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140741 · Cited by 272
γ-Secretase inhibitors and modulators
Golde, T. E., Koo, E. H., Felsenstein, K. M., Osborne, B. A., & Miele, L. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.06.005 · Cited by 272
Robakis, N., Wisniewski, H., Jenkins, E., Devine-Gage, E., Houck, G., Yao, X.-L., Ramakrishna, N., Wolfe, G., Silverman, W., & Ted Brown, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91754-5 · Cited by 268
Self-citationThe Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons
Plant, L. D., Boyle, J. P., Smith, I. F., Peers, C., & Pearson, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05531.2003 · Cited by 266
Aβ-degrading enzymes: potential for treatment of Alzheimer disease
Miners, J. S., Barua, N., Kehoe, P. G., Gill, S., & Love, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182345e46 · Cited by 265
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias
Yarchoan, M., Xie, S. X., Kling, M. A., Toledo, J. B., Wolk, D. A., Lee, E. B., Van Deerlin, V., Lee, V. M. Y., Trojanowski, J. Q., & Arnold, S. E. (2012) · Brain · doi:10.1093/brain/aws271 · Cited by 262
β‐Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
Carson, J. A., & Turner, A. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00855.x · Cited by 261
Soucek, T., Cumming, R., Dargusch, R., Maher, P., & Schubert, D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00367-2 · Cited by 258
Efficacy of Donepezil in Early-Stage Alzheimer Disease: A Randomized Placebo-Controlled Trial
Seltzer, B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1852 · Cited by 257
Genome-wide association studies in Alzheimer’s disease
Bertram, L., & Tanzi, R. E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp406 · Cited by 257
Alzheimer's disease: a re-examination of the amyloid hypothesis
Neve, R. L., & Robakis, N. K. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01168-5 · Cited by 256
Self-citationPresenilin-1 mutations and Alzheimer’s disease.
Kelleher, R. J., & Shen, J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619574114 · Cited by 255
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
The βA4 amyloid precursor protein binding to copper
Hesse, L., Beher, D., Masters, C. L., & Multhaup, G. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00658-x · Cited by 248
Morris, E., Chalkidou, A., Hammers, A., Peacock, J., Summers, J., & Keevil, S. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3228-x · Cited by 248
You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., Engbers, J. D. T., Lipton, S. A., Stys, P. K., & Zamponi, G. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110789109 · Cited by 243
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
Kim, C. K., Lee, Y. R., Ong, L., Gold, M., Kalali, A., & Sarkar, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215699 · Cited by 241
Alexander, G. C., Emerson, S., & Kesselheim, A. S. (2021) · JAMA · doi:10.1001/jama.2021.3854 · Cited by 240
The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
Carreiras, M., Mendes, E., Perry, M., Francisco, A., & Marco-Contelles, J. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990135 · Cited by 240
Zetterberg, H. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.90 · Cited by 234
THE FAMILIAL OCCURRENCE OF CREUTZFELDT-JAKOB DISEASE AND ALZHEIMER'S DISEASE
MASTERS, C. L., GAJDUSEK, D. C., & GIBBS, C. J. (1981) · Brain · doi:10.1093/brain/104.3.535 · Cited by 234
Köhler, C., Maes, M., Slyepchenko, A., Berk, M., Solmi, M., Lanctôt, K., & Carvalho, A. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160907093807 · Cited by 233
Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1
Okochi, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf541 · Cited by 229
Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer’s Disease
Xia, D., Watanabe, H., Wu, B., Lee, S. H., Li, Y., Tsvetkov, E., Bolshakov, V. Y., Shen, J., & Kelleher, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.010 · Cited by 228
Bhatia, R., Lin, H., & Lal, R. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1233 · Cited by 226
Conformational Differences between Two Amyloid β Oligomers of Similar Size and Dissimilar Toxicity
Ladiwala, A. R. A., Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., Van Nostrand, W. E., & Tessier, P. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.329763 · Cited by 225
Drachman, D. A. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.11.003 · Cited by 224
Rodent models for Alzheimer’s disease drug discovery
Puzzo, D., Gulisano, W., Palmeri, A., & Arancio, O. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1041913 · Cited by 222
White, A. R., Multhaup, G., Maher, F., Bellingham, S., Camakaris, J., Zheng, H., Bush, A. I., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09170.1999 · Cited by 222
Is Alzheimer’s disease a systemic disease?
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219
Some Speculations about Prions, Amyloid, and Alzheimer's Disease
Prusiner, S. B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403083101021 · Cited by 213
Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells
Anderson, J. P., Esch, F. S., Keim, P. S., Sambamurti, K., Lieberburg, I., & Robakis, N. K. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90775-o · Cited by 213
Self-citationMorris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Self-citationAccelerated Brain Volume Loss Caused by Anti–β-Amyloid Drugs: A Systematic Review and Meta-analysis
Alves, F., Kalinowski, P., & Ayton, S. (2023) · Neurology · doi:10.1212/wnl.0000000000207156 · Cited by 212
Alzheimer disease and aducanumab: adjusting our approach
Selkoe, D. J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0205-1 · Cited by 208
Greene, J. A., & Loscalzo, J. (2017) · New England Journal of Medicine · doi:10.1056/nejmms1706744 · Cited by 205
Copernicus revisited: amyloid beta in Alzheimer's disease
Josepha, J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00211-6 · Cited by 203
Reactivated herpes simplex infection increases the risk of Alzheimer's disease
Lövheim, H., Gilthorpe, J., Adolfsson, R., Nilsson, L.-G., & Elgh, F. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.522 · Cited by 202
Nicoll, J. A. R., Buckland, G. R., Harrison, C. H., Page, A., Harris, S., Love, S., Neal, J. W., Holmes, C., & Boche, D. (2019) · Brain · doi:10.1093/brain/awz142 · Cited by 202
Emerging roles of pathogens in Alzheimer disease
Miklossy, J. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002006 · Cited by 201
Maloney, J. A., Bainbridge, T., Gustafson, A., Zhang, S., Kyauk, R., Steiner, P., van der Brug, M., Liu, Y., Ernst, J. A., Watts, R. J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589069 · Cited by 197
Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain
Smith, M. A., Casadesus, G., Joseph, J. A., & Perry, G. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01021-3 · Cited by 189
Hypothesis on the Regulation of Cytosol Calcium Concentration and the Aging Brain
Khachaturian, Z. S. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90073-x · Cited by 187
Bacterial Infection and Alzheimer's Disease: A Meta-Analysis
Maheshwari, P., & Eslick, G. D. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140621 · Cited by 183
Hureau, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.037 · Cited by 178
Walker, E. S., Martinez, M., Brunkan, A. L., & Goate, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02858.x · Cited by 177
Lannfelt, L., Basun, H., Wahlund, L.-O., Rowe, B. A., & Wagner, S. L. (1995) · Nature Medicine · doi:10.1038/nm0895-829 · Cited by 175
Hoyer, S. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00156-x · Cited by 174
Vilalta, A., & Brown, G. C. (2018) · The FEBS Journal · doi:10.1111/febs.14323 · Cited by 174
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
Rönnemaa, E., Zethelius, B., Lannfelt, L., & Kilander, L. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330020 · Cited by 171
Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease
Crump, C. J., Johnson, D. S., & Li, Y.-M. (2013) · Biochemistry · doi:10.1021/bi400377p · Cited by 171
Matsuzaki, K. (2014) · Accounts of Chemical Research · doi:10.1021/ar500127z · Cited by 170
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
Kumar, D., Ganeshpurkar, A., Kumar, D., Modi, G., Gupta, S. K., & Singh, S. K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.035 · Cited by 170
Piller, C. (2022) · Science · doi:10.1126/science.add9993 · Cited by 169
CSF biomarker levels in early and late onset Alzheimer's disease
Bouwman, F. H., Schoonenboom, N. S. M., Verwey, N. A., van Elk, E. J., Kok, A., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.007 · Cited by 168
Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β
Korshavn, K. J., Satriano, C., Lin, Y., Zhang, R., Dulchavsky, M., Bhunia, A., Ivanova, M. I., Lee, Y.-H., La Rosa, C., Lim, M. H., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.764092 · Cited by 168
The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review
Rice, L., & Bisdas, S. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.07.014 · Cited by 168
Shea, Y. F., Chu, L., Chan, A. O.-K., Ha, J. C. T., Li, Y., & Song, Y. (2015) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.08.004 · Cited by 167
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 167
Self-citationRevisiting FDA Approval of Aducanumab
Alexander, G. C., Knopman, D. S., Emerson, S. S., Ovbiagele, B., Kryscio, R. J., Perlmutter, J. S., & Kesselheim, A. S. (2021) · New England Journal of Medicine · doi:10.1056/nejmp2110468 · Cited by 162
γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer’s Drugs
Oehlrich, D., Berthelot, D. J.-C., & Gijsen, H. J. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101168r · Cited by 161
Kalback, W., Esh, C., Castaño, E. M., Rahman, A., Kokjohn, T., Luehrs, D. C., Sue, L., Cisneros, R., Gerber, F., Richardson, C., et al. (2004) · Neurological Research · doi:10.1179/016164104225017668 · Cited by 160
Neve, R. L., McPhie, D. L., & Chen, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02869-9 · Cited by 160
Georgakopoulos, A., Litterst, C., Ghersi, E., Baki, L., Xu, C., Serban, G., & Robakis, N. K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601031 · Cited by 160
Self-citationCopper: from neurotransmission to neuroproteostasis
Opazo, C. M., Greenough, M. A., & Bush, A. I. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00143 · Cited by 160
Kang, J., Korecka, M., Toledo, J. B., Trojanowski, J. Q., & Shaw, L. M. J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.202937 · Cited by 159
Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 157
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US
Ross, E. L., Weinberg, M. S., & Arnold, S. E. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.0315 · Cited by 155
Bulloj, A., Leal, M. C., Xu, H., Castaño, E. M., & Morelli, L. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1206 · Cited by 154
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
Bickeböller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., Penet, C., Martin, C., Pérez‐Tur, J., Michon, A., et al. (1997) · Europe PMC (PubMed Central) · Cited by 153
Rosenblum, W. I. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.085 · Cited by 153
Talbot, K., & Wang, H.-Y. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.007 · Cited by 151
Hureau, C., & Dorlet, P. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.034 · Cited by 149
Smith, I. F., Green, K. N., & LaFerla, F. M. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.021 · Cited by 148
The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase
Bolduc, D. M., Montagna, D. R., Seghers, M., Wolfe, M. S., & Selkoe, D. J. (2016) · eLife · doi:10.7554/elife.17578 · Cited by 147
Haass, C., & Selkoe, D. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001694 · Cited by 145
Cerebral amyloid PET imaging in Alzheimer’s disease
Jack, C. R., Barrio, J. R., & Kepe, V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1185-7 · Cited by 144
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
Schwab, C., Hosokawa, M., & McGeer, P. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.016 · Cited by 144
Stem cell models of Alzheimer’s disease: progress and challenges
Arber, C., Lovejoy, C., & Wray, S. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0268-4 · Cited by 143
A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory
Morley, J. E., Farr, S. A., Banks, W. A., Johnson, S. N., Yamada, K. A., & Xu, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1230 · Cited by 141
γ‐Secretase inhibitors and modulators for Alzheimer’s disease
Wolfe, M. S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07501.x · Cited by 139
Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’
Castellani, R. J., & Smith, M. A. (2011) · The Journal of Pathology · doi:10.1002/path.2885 · Cited by 138
Sturchio, A., Dwivedi, A. K., Young, C. B., Malm, T., Marsili, L., Sharma, J. S., Mahajan, A., Hill, E. J., Andaloussi, S. E., Poston, K. L., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100988 · Cited by 136
Making the final cut: Pathogenic amyloid-β peptide generation by γ-secretase
Steiner, H., Fukumori, A., Tagami, S., & Okochi, M. (2018) · Cell Stress · doi:10.15698/cst2018.11.162 · Cited by 133
Familial Alzheimer’s Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds
Veugelen, S., Saito, T., Saido, T. C., Chávez‐Gutiérrez, L., & Strooper, B. D. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.010 · Cited by 129
Alzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 128
Self-citationGomes, L. A., Hipp, S. A., Rijal Upadhaya, A., Balakrishnan, K., Ospitalieri, S., Koper, M. J., Largo-Barrientos, P., Uytterhoeven, V., Reichwald, J., Rabe, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02053-5 · Cited by 125
Alzheimer's disease genetics: current knowledge and future challenges
Hollingworth, P., Harold, D. H., Jones, L., Owen, M. J., & Williams, J. H. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2628 · Cited by 124
Questions EMERGE as Biogen claims aducanumab turnaround
Howard, R., & Liu, K. Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0295-9 · Cited by 123
On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis
Castello, M. A., & Soriano, S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.10.001 · Cited by 122
The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies
Arenaza‐Urquijo, E. M., Przybelski, S. A., Lesnick, T. G., Graff‐Radford, J., Machulda, M. M., Knopman, D. S., Schwarz, C. G., Lowe, V. J., Mielke, M. M., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz037 · Cited by 121
Wilcock, D. M., & Colton, C. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15404 · Cited by 120
Tayeb, H. O., Murray, E. D., Price, B. H., & Tarazi, F. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.789856 · Cited by 119
Learning by Failing: Ideas and Concepts to Tackle γ-Secretases in Alzheimer's Disease and Beyond
De Strooper, B., & Chávez Gutiérrez, L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124309 · Cited by 119
Is the Amyloid Hypothesis of Alzheimer's disease therapeutically relevant?
Teich, A. F., & Arancio, O. (2012) · Biochemical Journal · doi:10.1042/bj20120653 · Cited by 119
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease
Cohen, A. D., Landau, S. M., Snitz, B. E., Klunk, W. E., Blennow, K., & Zetterberg, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.004 · Cited by 119
Mullane, K., & Williams, M. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113945 · Cited by 115
Dahl, A., & Hassing, L. B. (2012) · Epidemiologic Reviews · doi:10.1093/epirev/mxs002 · Cited by 114
Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress
Castellani, R. J., & Perry, G. L. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.09.009 · Cited by 113
Wu, B., Yamaguchi, H., Lai, F. A., & Shen, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304171110 · Cited by 113
Oxidative stress in Alzheimer's disease
Gibson, G. E., & Huang, H. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.017 · Cited by 111
Carotid Atherosclerosis and Prospective Risk of Dementia
Wendell, C. R., Waldstein, S. R., Ferrucci, L., O’Brien, R., Strait, J. B., & Zonderman, A. B. (2012) · Stroke · doi:10.1161/strokeaha.112.672527 · Cited by 111
Fukumori, A., Fluhrer, R., Steiner, H., & Haass, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1443-10.2010 · Cited by 105
Alzheimer's disease: The amyloid hypothesis on trial
Harrison, J. R., & Owen, M. J. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.167569 · Cited by 105
Genotype and phenotype in Alzheimer's disease
Holmes, C. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.131 · Cited by 104
Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples
Watt, A. D., Perez, K. A., Rembach, A., Sherratt, N. A., Hung, L. W., Johanssen, T., McLean, C., Kok, W. M., Hutton, C. A., Fodero‐Tavoletti, M. T., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1083-z · Cited by 103
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 103
Lecanemab for Alzheimer's disease: tempering hype and hope
Lancet, T. (2022) · The Lancet · doi:10.1016/s0140-6736(22)02480-1 · Cited by 101
Shioi, J., Georgakopoulos, A., Mehta, P. D., Kouchi, Z., Litterst, C. M., Baki, L., & Robakis, N. K. R. K. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04391.x · Cited by 100
Self-citationLysosome and calcium dysregulation in Alzheimer's disease: partners in crime
McBrayer, M. K., & Nixon, R. A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130201 · Cited by 100
Lansdall, C. J., McDougall, F., Butler, L. M., Delmar, P., Pross, N., Qin, S., McLeod, L., Zhou, X., Kerchner, G. A., & Doody, R. S. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2022.102 · Cited by 99
Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis
Supnet, C. B., & Борисович, Б. И. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.05.013 · Cited by 96
Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 96
Self-citationAmyloid-β Positron Emission Tomography Imaging Probes: A Critical Review
Kepe, V., Moghbel, M. C., Långström, B., Zaidi, H., Vinters, H. V., Huang, S., Satyamurthy, N., Doudet, D. J., Mishani, E., Cohen, R. M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130485 · Cited by 90
Self-citationTen Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
Kepp, K. P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160550 · Cited by 89
Self-citationOxidative metabolism deficiencies in brains of patients with Alzheimer's disease
Hoyer, S. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05868.x · Cited by 88
Review: The genetics of A lzheimer's disease; putting flesh on the bones
Medway, C., & Morgan, K. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12101 · Cited by 88
New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
Corona, C., Pensalfini, A., Frazzini, V., & Sensi, S. L. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.57 · Cited by 88
Self-citationVillain, N., Planche, V., & Levy, R. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.06.012 · Cited by 87
Wessels, A. M., Siemers, E. R., Yu, P., Andersen, S. W., Holdridge, K. C., Sims, J. R., Sundell, K., Stern, Y., Rentz, D. M., Dubois, B., et al. (2015) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2015.82 · Cited by 86
Cestari, J. A. F., Fabri, G. M. C., Kalil, J. E., Nitríni, R., Filho, W. J., de Siqueira, J. T. T., & de Siqueira, S. R. D. T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160212 · Cited by 84
Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives
Robakis, N. K. R. K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.022 · Cited by 83
Self-citationA mathematical model of aging-related and cortisol induced hippocampal dysfunction
Auley, M. T. M., Kenny, R. A., Kirkwood, T. B. L., Wilkinson, D. J., Jones, J. J., & Miller, V. M. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-26 · Cited by 81
Kretner, B., Trambauer, J., Fukumori, A., Mielke, J., Kuhn, P., Kremmer, E., Giese, A., Lichtenthaler, S. F., Haass, C., Arzberger, T., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505952 · Cited by 76
Lecanemab for Alzheimer’s disease
Walsh, S., Merrick, R., Richard, E., Nurock, S., & Brayne, C. (2022) · BMJ · doi:10.1136/bmj.o3010 · Cited by 76
α‐Secretase Activity of the Disintegrin Metalloprotease ADAM 10: Influences of Domain Structure
Fahrenholz, F., GILBERT, S., Kojro, E., Lammich, S., & Postina, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06925.x · Cited by 75
SOD1 and mitochondria in ALS: a dangerous liaison
Carrì, M. T., & Cozzolino, M. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9394-z · Cited by 75
The dark sides of amyloid in Alzheimer's disease pathogenesis
Sorrentino, P., Iuliano, A., Polverino, A., Jacini, F., & Sorrentino, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.12.038 · Cited by 75
Cacquevel, M., Aeschbach, L., Houacine, J., & Fraering, P. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035133 · Cited by 75
Bolognesi, B., & Lehner, B. (2018) · eLife · doi:10.7554/elife.39804 · Cited by 73
Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R. H., & Feng, J. (2014) · Apollo (University of Cambridge) · doi:10.17863/cam.30626 · Cited by 72
Körte, M., Herrmann, U., Zhang, X., & Draguhn, A. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2894-6 · Cited by 69
FDA approval for Biogen’s aducanumab sparks Alzheimer disease firestorm
Mullard, A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/d41573-021-00099-3 · Cited by 69
Arson: Tracking the Culprit in Alzheimer's Disease
Smith, M. A., Joseph, J. A., & Perry, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05557.x · Cited by 68
The amyloid hypothesis: let sleeping dogmas lie?
Bishop, G. M., & Robinson, S. R. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00050-7 · Cited by 67
What is the Physiological Function of Amyloid-Beta Protein?
Morley, J. E., Farr, S. A., Nguyen, A. D., & Xu, F. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1162-5 · Cited by 66
Bour, A., Little, S. P., Dodart, J., Kelche, C. R., & Mathis, C. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00071-6 · Cited by 63
Pharmacotherapeutic targets in Alzheimer's disease
Biran, Y., Masters, C. L., Barnham, K. J., Bush, A. I., & Adlard, P. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00595.x · Cited by 63
de la Monte, S. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_4 · Cited by 62
Brender, J., Heyl, D., Samisetti, S., Kotler, S. A., Osborne, J. M., Pesaru, R. R., & Ramamoorthy, A. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp44696d · Cited by 59
Lecanu, L., Greeson, J., & Papadopoulos, V. (2005) · Pharmacology · doi:10.1159/000088929 · Cited by 59
Processive proteolysis by γ-secretase and the mechanism of Alzheimer’s disease
Wolfe, M. (2012) · Biological chemistry · doi:10.1515/hsz-2012-0140 · Cited by 58
Sturchio, A., (DIAN), T. D. I. A. C., Dwivedi, A. K., Malm, T., Wood, M. J. A., Cilia, R., Sharma, J. S., Hill, E. J., Schneider, L. S., Graff-Radford, N. R., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220808 · Cited by 57
Tsuchida, K., Shioi, J., Yamada, S., Boghosian, G., Wu, A., Cai, H., Sugahara, K., & Robakis, N. K. R. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105818200 · Cited by 57
Self-citationAmyloid precursor protein, copper and Alzheimer's disease
Multhaup, G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)86907-7 · Cited by 57
The pathological interaction between diabetes and presymptomatic Alzheimer's disease
Burdo, J. R., Chen, Q., Calcutt, N. A., & Schubert, D. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.010 · Cited by 55
Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer's disease
Richard, E., den Brok, M. G. H. E., & van Gool, W. A. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12379 · Cited by 54
Moghbel, M. C., Saboury, B., Basu, S. K., Metzler, S. D., Torigian, D. A., Långström, B., & Alavi, A. A. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1960-4 · Cited by 53
Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease
Somavarapu, A. K., & Kepp, K. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13535 · Cited by 53
Self-citationSuárez‐Calvet, M., Belbin, O., Pera, M., Badiola, N., Magrané, J., Guardia‐Laguarta, C., Muñoz, L., Colom‐Cadena, M., Clarimón, J., & Lleó, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12466 · Cited by 51
Lecanemab trial in AD brings hope but requires greater clarity
Thambisetty, M., & Howard, R. J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-022-00768-w · Cited by 51
Toda, N., Ayajiki, K., & Okamura, T. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910120456 · Cited by 50
Three FDA advisory panel members resign over approval of Alzheimer’s drug
Mahase, E. (2021) · BMJ · doi:10.1136/bmj.n1503 · Cited by 50
Membrane Dynamics of γ-Secretase Provides a Molecular Basis for β-Amyloid Binding and Processing
Somavarapu, A. K., & Kepp, K. P. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00208 · Cited by 49
Self-citationSoluble Amyloid-β Consumption in Alzheimer’s Disease
Espay, A. J., Sturchio, A., Schneider, L. S., & Ezzat, K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210415 · Cited by 49
Cardiovascular Risk Profile in Women and Dementia
Dufouil, C., Seshadri, S. S., & Chêne, G. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141629 · Cited by 46
Cellular mechanisms of γ-secretase substrate selection, processing and toxicity
Barthet, G., Georgakopoulos, A., & Robakis, N. K. R. K. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.006 · Cited by 46
Self-citationAlavi, A. A., Werner, T. J., Høilund‐Carlsen, P. F., & Zaidi, H. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1146-y · Cited by 45
Self-citationAβ 42 /Aβ 40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer’s Disease
Tang, N., & Kepp, K. P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180829 · Cited by 45
Self-citationAyton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Amyloid‐β: A vascular sealant that protects against hemorrhage?
Atwood, C. S., Bishop, G. M., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10388 · Cited by 44
Dysregulation of the proteasome increases the toxicity of ALS ‐linked mutant SOD 1
Kitamura, A., Inada, N., KUBOTA, H. Y., Matsumoto, G., Kinjo, M., Morimoto, R. I., & Nagata, K. (2014) · Genes to Cells · doi:10.1111/gtc.12125 · Cited by 44
Loss of Aβ43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain
Xia, D., Kelleher, R. J., & Shen, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.009 · Cited by 43
An Appropriate Use of Accelerated Approval — Aducanumab for Alzheimer’s Disease
Dunn, B., Stein, P., Temple, R., & Cavazzoni, P. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2111960 · Cited by 42
Solanezumab and the amyloid hypothesis for Alzheimer’s disease
Couteur, D. G. L., Hunter, S., & Brayne, C. (2016) · BMJ · doi:10.1136/bmj.i6771 · Cited by 42
β‐Amyloid pathogenesis: Chemical properties versus cellular levels
Tiwari, M. K., & Kepp, K. P. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.1895 · Cited by 41
Self-citationIntegrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates
Wessels, A. M., Rentz, D. M., Case, M. G., Lauzon, S., & Sims, J. R. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12312 · Cited by 41
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease
Levin, J., Vöglein, J., Quiroz, Y. T., Bateman, R. J., Ghisays, V., Lopera, F., McDade, E., Reiman, E., Tariot, P. N., & Morris, J. C. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12624 · Cited by 40
Sevigny, J., Chiao, P., Williams, L. J., Chen, T., Ling, Y., O'Gorman, J., Höck, C., Nitsch, R. M., & Sandrock, A. W. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.07.367 · Cited by 40
Role of potassium channels in Aβ1–40‐activated apoptotic pathway in cultured cortical neurons
Yu, H., Li, Z., Zhang, H., & Wang, X. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21054 · Cited by 39
Malgieri, G., & Grasso, G. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.10.008 · Cited by 35
Bäckman, K., Joas, E., Wærn, M., Östling, S., Guo, X., Blennow, K., Skoog, I. G., & Gustafson, D. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150326 · Cited by 34
Dehury, B., Tang, N., Mehra, R., Blundell, T. L., & Kepp, K. P. (2020) · RSC Advances · doi:10.1039/d0ra04683c · Cited by 34
Self-citationObesity in middle age and future risk of dementia: Midlife obesity increases risk of future dementia
Razay, G., & Vreugdenhil, A. (2005) · BMJ · doi:10.1136/bmj.331.7514.455 · Cited by 32
Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
Steffen, J., Krohn, M., Schwitlick, C., Brüning, T., Paarmann, K., Pietrzik, C. U., Biverstål, H., Jansone, B., Langer, O., & Pahnke, J. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0448-2 · Cited by 32
Cai, T., Yonaga, M., & Tomita, T. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1628-17.2017 · Cited by 32
Trambauer, J., Sarmiento, R. M. R., Fukumori, A., Feederle, R., Baumann, K., & Steiner, H. (2019) · EMBO Reports · doi:10.15252/embr.201947996 · Cited by 32
Aducanumab for Alzheimer disease: the amyloid hypothesis moves from bench to bedside
Musiek, E. S., Gómez‐Isla, T., & Holtzman, D. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci154889 · Cited by 32
Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
Tate, B. A., McKee, T. D., Loureiro, R. M. B., Dumin, J. A., Xia, W., Pojasek, K., Austin, W., Fuller, N. O., Hubbs, J. L., Shen, R., et al. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/210756 · Cited by 31
Alavi, A. A., Barrio, J. R., Werner, T. J., Khosravi, M., Newberg, A. B., & Høilund‐Carlsen, P. F. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04564-5 · Cited by 30
Self-citationγ-Secretase as a Target for Alzheimers Disease
Wolfe, M. S. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607535 · Cited by 28
Massetti, N., Russo, M., Franciotti, R., Nardini, D., Mandolini, G. M., Granzotto, A., Bomba, M., Pizzi, S. D., Mosca, A., Scherer, R., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210573 · Cited by 27
Self-citationAducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data
Høilund‐Carlsen, P. F., & Alavi, A. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215275 · Cited by 26
Self-citationModeling the Aggregation Propensity and Toxicity of Amyloid-β Variants
Tiwari, M. K., & Kepp, K. P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150046 · Cited by 25
Self-citation
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“78,111,112 115 However, FAD mutations are not necessarily linked to an increase in A β 42 levels or an elevation of A β 42 /A β 40 ratio.”
BackgroundAnti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Fedele, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914499 · Cited by 102
Kamila, P., Kar, K., Chowdhury, S., Chakraborty, P., Dutta, R., S, S., Singh S, A., & Prajapati, B. G. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.005 · Cited by 90
Granzotto, A., Vissel, B., & Sensi, S. L. (2024) · eLife · doi:10.7554/elife.90633 · Cited by 71
Self-citationOnce upon a time, the Amyloid Cascade Hypothesis
Granzotto, A., & Sensi, S. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102161 · Cited by 57
Self-citation
Metadata
- Authors
- Kepp, K. P., Robakis, N. K., Høilund-Carlsen, P. F., Sensi, S. L., & Vissel, B.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-05-15
- Volume
- 146
- Issue
- 10
- Pages
- 3969-3990
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W4376614794
- Cited by
- 284
- References
- 436
- FWCI
- 41.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.